23andMe Research

New data from 23andMe shows that although people became less active early in the COVID-19 pandemic, activity-levels measured in steps have gone back up.

This week 23andMe scientists published findings from the first four months of our COVID-19 study using data from more than a million research participants that found both genetic and non-genetic...

A majority of people have at least one genetic variant in the CYP2C19 gene that may alter how their bodies process commonly prescribed drugs.

23andMe shares insights from its Lupus Research Study, one of the largest genetic studies of the condition to date. Although the study did not find any new genetic associations, the research did reveal new details on symptoms, and associated conditions.

23andMe’s research into COVID-19 reveals that amid the pandemic between April and June, adherence to social distancing measures waned, only to go back up in July as cases spiked again.

Blacks and Latinos are disproportionately affected by COVID-19, according to new data from scientists at 23andMe, illustrating the racial disparities in the impact of the virus.

Published today in the American Journal of Human Genetics, a paper by 23andMe scientists using genetic data offers one of the most comprehensive investigations of the transatlantic slave trade ever done.

Using data from the UK Biobank and 23andMe, researchers found new genetic associations for allergies, asthma, and eczema by studying the age of onset.

People are walking a lot less and sleeping more since efforts to slow the spread of COVID-19 began in March, according to new data compiled by 23andMe. Researchers looked at data from 33,000 individuals, who consented to participate in research, and included about 20 million data points tracking more than two months of activity. While we know the virus itself presents serious health risks, these changes in daily behavior may also impact our health in more subtle ways.

Preliminary data from 23andMe's massive COVID-19 study lends more support to the importance of blood type in susceptibility to the virus and the severity of symptoms. Early data indicate that the O blood type may be protective against COVID-19.